Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MEK2 anticorps

MAP2K2 Reactivité: Humain, Souris, Rat WB Hôte: Souris Monoclonal unconjugated
N° du produit ABIN7305212
  • Antigène Voir toutes MEK2 (MAP2K2) Anticorps
    MEK2 (MAP2K2) (Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2))
    Reactivité
    • 135
    • 82
    • 47
    • 7
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain, Souris, Rat
    Hôte
    • 109
    • 25
    • 1
    • 1
    Souris
    Clonalité
    • 110
    • 26
    Monoclonal
    Conjugué
    • 72
    • 11
    • 11
    • 10
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp MEK2 est non-conjugé
    Application
    • 110
    • 61
    • 35
    • 22
    • 21
    • 20
    • 18
    • 15
    • 14
    • 9
    • 7
    • 4
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Specificité
    Recognizes endogenous levels of MKK2 protein.
    Attributs du produit
    Mouse monoclonal to MKK2
    Immunogène
    Recombinant protein corresponding to human MKK2.
    Top Product
    Discover our top product MAP2K2 Anticorps primaire
  • Indications d'application
    WB (1:1000 - 1:2000)
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
    Date de péremption
    12 months
  • Antigène
    MEK2 (MAP2K2) (Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2))
    Autre désignation
    MKK2 (MAP2K2 Produits)
    Synonymes
    anticorps CFC4, anticorps MAPKK2, anticorps MEK2, anticorps MKK2, anticorps PRKMK2, anticorps AA589381, anticorps MK2, anticorps Prkmk2, anticorps ATMKK2, anticorps F27B13.50, anticorps F27B13_50, anticorps MAP KINASE KINASE 1, anticorps MAP kinase kinase 2, anticorps MK1, anticorps map2k2, anticorps wu:fa56c06, anticorps zgc:123171, anticorps zgc:172250, anticorps mitogen-activated protein kinase kinase 2, anticorps mitogen activated protein kinase kinase 2, anticorps MAP kinase kinase 2, anticorps mitogen-activated protein kinase kinase 2a, anticorps mitogen-activated protein kinase kinase 2b, anticorps MAP2K2, anticorps Map2k2, anticorps MKK2, anticorps map2k2a, anticorps map2k2b
    Sujet
    MEK2, MKK2, PRKMK2, Dual specificity mitogen-activated protein kinase kinase 2, MAP kinase kinase 2, MAPKK 2, ERK activator kinase 2, MAPK/ERK kinase 2, MEK 2
    ID gène
    5605
    UniProt
    P36507
    Pathways
    Signalisation MAPK, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Toll-Like Receptors Cascades, Signaling of Hepatocyte Growth Factor Receptor, BCR Signaling
Support technique